NERV

Minerva Neurosciences, Inc.

NERV · CIK 1598646 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$0M
20172024
Net Income$1M
20172024
Operating CF−$20M
20172024
Free Cash Flow
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue————————
Gross Profit————————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B
EPS (Basic)$0.19$-4.61$-6.01$-1.17$0.05———
EPS (Diluted)$0.19$-4.61$-6.01$-1.17$0.05———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.2B
Current Assets$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.1B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.1B$0.0B
Total Liabilities$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.1B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.0B$-0.0B$-0.0B$0.0B$0.1B$0.0B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Investing Cash Flow$0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B$0.1B—
Capital Expenditures—$0.0B$0.0B———$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$-0.0B$0.1B$0.0B$0.0B$-0.0B—
← Companies